Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Guidance downgrade disappoints

Aroa Biosurgery
3:27pm
January 29, 2025
ARX has posted 3Q25 operating cashflow of NZ$1.2m which was in line with our expectations. However, we were disappointed with the lower revenue guidance which despite a currency benefit implies softer demand than expected for 3Q/4Q. There have been a number of slips in guidance over the last two years and the market has become less tolerant as was reflected in the 20% share price drop. We have adjusted our FY25 forecast to the lower end of FY25 guidance and revised down our growth expectations for FY26/27 by ~5%. As a result our valuation and target price have been revised down to A$0.93 (from A$1.05). We have maintained or Add recommendation although recognise it will take a few quarters to rebuild investor confidence.

On solid footing awaiting the steel recovery

Stanmore Resources
3:27pm
January 28, 2025
4Q production was again typically solid, with management suggesting good momentum will continue through CY25. SMR trades at less than 0.7x P/NPV, reflecting depressed investor interest and confidence in global steel dynamics. We think that met coal market weakness has found its floor, however increased patience looks required as macro forces play out. Maintain ADD with a positive structural view on HCC markets in the medium term.

Model update

Rio Tinto
3:27pm
January 28, 2025
We have made some updates to our model for Rio Tinto (ASX: RIO) ahead of the February full-year reporting season. Our NPAT estimate has changed by -4.2% in 2024F to US$10,940m, and increased +1.3% to US$12,241m in 2025F. Our price target is unchanged at A$125 per share. Our rating is also unchanged at Add.

Good output but cash flow disappoints

Fortescue
3:27pm
January 23, 2025
FMG capped off an impressive half in operational terms, setting a fresh record for the half year in shipments, and reduction in C1 unit costs. Cash balance at 31 December fell ~US$0.7bn short of estimates, driven by FX losses, an increase in working capital and employee expenses. The jury is still out on why FMG’s high-grade Iron Bridge product is not achieving the pricing expected. FMG points to market dynamics, but it is worth monitoring. All FY25 guidance for shipments, C1 costs, energy opex/capex and metals capex was maintained. We maintain a Hold rating, with an updated A$18.90 (was A$20.50) target price.

2Q25 Result: Numerous Records Broken

Regis Resources
3:27pm
January 23, 2025
Q2 FY25 delivered 101.3koz of gold production at an AISC of A$2,317/oz, 12% below the FY25 guidance midpoint of A$2,590/oz, following record production at Tropicana. Guidance has been reiterated. Quarterly unit costs, revenue, milled tonnes, and the achieved gold price all outperformed Morgans' forecasts, supporting strong operational performance and enhancing consistent cash generation. Following the December quarter, RRL repaid the existing A$300m syndicated loan facility. The company is now unhedged and debt-free. We maintain our ADD rating and have raised our price target to A$3.83ps (previously A$3.22ps).

Weathering through the cyclical low

Coronado Global Resources
3:27pm
January 23, 2025
Weak 4Q cash outflow was in-line and is primarily a function of weaker-than-expected global steel markets since mid-2024. CRN has made gains on production and cost improvements, but cash leakage means the market is rightly placing a sharp focus on liquidity and balance sheet buffers. At spot HCC prices, we think CRN can weather another ~3 quarters before total available liquidity tests CRN’s notional comfort level. CRN is very cheap, but risks are ratcheting higher. Our rating/ target price relies on sound execution, but critically a 2025 rebound in steel market fundamentals.

Target reached, but still looking for confirmation

Nanosonics
3:27pm
January 23, 2025
NAN provided a strong trading update and indicated its expectations to achieve the top-end of its FY25 guidance range. Questions remain around install base growth and budgetary pressures in the hospital which overhangs the stock ahead of a pending FDA approval and launch of the CORIS device. With a strong rally in the share price over the last month, our target price has been reached and as a result we pare our recommendation back to a Hold (from Add). While we see potential risk to the upside in FY25 guidance and outlook commentary at the result, we’re happy to see this play out to get more confidence on the hospital environment as well as timing around CORIS before getting more positive.

2Q25 update – An impressive performance

Generation Development Group
3:27pm
January 22, 2025
GDG delivered a very strong 2Q25 update, punctuated by record Investment bond sales of A$250m (a 3rd consecutive record quarter for the company). The key takeaway from the quarterly for us, is it confirmed the Investment Bond business appears to have delivered a step change in growth in recent quarters. We lift our GDG FY25F/FY26F EPS by 6%-10% on higher sales/FUM growth expectations in the Investment Bond business. Our PT rises to A$4.75 on our earnings changes and a lift to longer-term growth assumptions in our valuation. We think GDG has a great story, and management has executed very well. With the recent quarterly pointing to growth and sales momentum above our expectations, and the stock trading at a >10% discount to our PT, we move back to an ADD recommendation.

2Q25 result: Strong production, net debt increasing

BHP Group
3:27pm
January 22, 2025
A strong 2Q operating performance from BHP, with WAIO, BMA, NSWEC and Samarco all tracking to the upper half of FY25 production guidance. All guidance maintained, outside of Copper South Australia (modest revision). Net debt guided to US$11.5-$12.5bn at 31 December. Jansen Stage 1 remains on schedule and budget. We maintain an ADD rating for BHP and A$.10 target price (was A$).

2Q25 Result: East Wall Remediation Unlocks a Stronger Second Half

Northern Star Resources
3:27pm
January 21, 2025
2Q25 delivered 410koz of gold sales (307koz mined) at an AISC of A$2,128/oz, within our estimates. FY25 guidance has been maintained. KCGM East Wall Remediation is complete, unlocking the higher-grade Golden Pike North, which will drive 2H25 production and earnings. Growth at KCGM remains on track, engineering, design, construction progressing as scheduled. All major equipment has been delivered to site or country. The pending acquisition of De Grey Mining (DEG.ASX) reaffirms NST's commitment to growth.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more